Literature DB >> 30126588

Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome.

R De Vincenzo1, L Tortorella1, C Ricci1, A F Cavaliere2, G F Zannoni3, M G Cefalo4, G Scambia1, A Fagotti5.   

Abstract

A case of stage IB2 cervical cancer at 27 weeks of pregnancy, treated with neoadjuvant chemotherapy followed by radical Cesarean hysterectomy with full pelvic and infra-mesenteric lymphadenectomy, and adjuvant chemo-radiation is described. While she remains without disease, her baby was diagnosed with acute myelogenous leukemia. We highlight the pre-operative work-up, treatment options, safety, feasibility, and outcomes for the mother and her fetus.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Neoadjuvant chemotherapy; Obstetric outcome; Pregnancy; Radical hysterectomy

Mesh：

Substances：

Year:  2018        PMID： 30126588     DOI： 10.1016/j.ygyno.2018.06.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


  6 in total

1.  Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.

Authors:  Tanja Fehm; Frederik A Stübs; Martin C Koch; Peter Mallmann; Christian Dannecker; Anna Dietl; Anna Sevnina; Franziska Mergel; Laura Lotz; Anne Ehret; Daniel Gantert; Franca Martignoni; Jan-Philipp Cieslik; Jan Menke; Olaf Ortmann; Carmen Stromberger; Karin Oechsle; Beate Hornemann; Friederike Mumm; Christoph Grimm; Alina Sturdza; Edward Wight; Kristina Loessl; Michael Golatta; Volker Hagen; Timm Dauelsberg; Ingo Diel; Karsten Münstedt; Eberhard Merz; Dirk Vordermark; Katja Lindel; Christian Wittekind; Volkmar Küppers; Ralph Lellé; Klaus Neis; Henrik Griesser; Birgit Pöschel; Manfred Steiner; Ulrich Freitag; Tobias Gilster; Alexander Schmittel; Michael Friedrich; Heidemarie Haase; Marion Gebhardt; Ludwig Kiesel; Michael Reinhardt; Michael Kreißl; Marianne Kloke; Lars-Christian Horn; Regina Wiedemann; Simone Marnitz; Anne Letsch; Isabella Zraik; Bernhard Mangold; Jochen Möckel; Céline Alt; Pauline Wimberger; Peter Hillemanns; Kerstin Paradies; Alexander Mustea; Dominik Denschlag; Ulla Henscher; Reina Tholen; Simone Wesselmann; Matthias W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-02-11       Impact factor: 2.915

2.  Treatment and clinical outcomes of cervical cancer during pregnancy.

Authors:  Jing Ma; Lan Yu; Fan Xu; Hongyan Yi; Wenfei Wei; Peng Wu; Sha Wu; Hua Li; Hong Ye; Wei Wang; Hui Xing; Liangsheng Fan
Journal:  Ann Transl Med       Date:  2019-06

3.  Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis.

Authors:  Yizuo Song; Yi Liu; Min Lin; Bo Sheng; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2018-12-19       Impact factor: 4.162

Review 4.  Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview.

Authors:  Giuseppe Gullo; Andrea Etrusco; Gaspare Cucinella; Antonino Perino; Vito Chiantera; Antonio Simone Laganà; Rossella Tomaiuolo; Amerigo Vitagliano; Pierluigi Giampaolino; Marco Noventa; Alessandra Andrisani; Giovanni Buzzaccarini
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

Review 5.  Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.

Authors:  Anna Franca Cavaliere; Federica Perelli; Simona Zaami; Marco D'Indinosante; Irene Turrini; Marco Giusti; Giuseppe Gullo; Giuseppe Vizzielli; Alberto Mattei; Giovanni Scambia; Annalisa Vidiri; Fabrizio Signore
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

6.  Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study.

Authors:  Federica Bernardini; Gabriella Ferrandina; Caterina Ricci; Anna Fagotti; Francesco Fanfani; Anna Franca Cavaliere; Benedetta Gui; Giovanni Scambia; Rosa De Vincenzo
Journal:  Curr Oncol       Date:  2022-08-14       Impact factor: 3.109
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.